OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Increased levels of the synaptic proteins PSD-95, SNAP-25, and neurogranin in the cerebrospinal fluid of patients with Alzheimer’s disease
Pia Kivisäkk, Becky C. Carlyle, Thadryan Sweeney, et al.
Alzheimer s Research & Therapy (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

p75 neurotrophin receptor modulation in mild to moderate Alzheimer disease: a randomized, placebo-controlled phase 2a trial
Hayley R. C. Shanks, Kewei Chen, Eric M. Reiman, et al.
Nature Medicine (2024) Vol. 30, Iss. 6, pp. 1761-1770
Open Access | Times Cited: 17

Emergence of Extracellular Vesicles as “Liquid Biopsy” for Neurological Disorders: Boom or Bust
Ashish Kumar, Michael A. Nader, Gagan Deep
Pharmacological Reviews (2023) Vol. 76, Iss. 2, pp. 199-227
Open Access | Times Cited: 30

Molecular mechanisms and therapeutic potential of icariin in the treatment of Alzheimer's disease
Lingyan Zheng, Sichen Wu, Haichao Jin, et al.
Phytomedicine (2023) Vol. 116, pp. 154890-154890
Closed Access | Times Cited: 22

Synapse vulnerability and resilience underlying Alzheimer’s disease
Raquel N. Taddei, Karen Duff
EBioMedicine (2025) Vol. 112, pp. 105557-105557
Open Access | Times Cited: 1

Alzheimer's disease neuropathology and its estimation with fluid and imaging biomarkers
Dietmar Rudolf Thal, Koen Poesen, Rik Vandenberghe, et al.
Molecular Neurodegeneration (2025) Vol. 20, Iss. 1
Open Access | Times Cited: 1

Traumatic brain injury and post‐traumatic stress disorder are not associated with Alzheimer's disease pathology measured with biomarkers
Michael W. Weiner, Danielle Harvey, Susan Landau, et al.
Alzheimer s & Dementia (2022) Vol. 19, Iss. 3, pp. 884-895
Open Access | Times Cited: 36

The use of synaptic biomarkers in cerebrospinal fluid to differentiate behavioral variant of frontotemporal dementia from primary psychiatric disorders and Alzheimer’s disease
Shreyasee Das, Marie‐Paule E. van Engelen, Julie Goossens, et al.
Alzheimer s Research & Therapy (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 5

Resilience mechanisms underlying Alzheimer’s disease
Christopher Chew, Lee Jy, Khuen Yen Ng, et al.
Metabolic Brain Disease (2025) Vol. 40, Iss. 1
Closed Access

Peripheral Mitochondrial Transplantation Alleviates Diabetes-Associated Cognitive Dysfunction by Suppressing Cuproptosis
Juan Hu, Qiao Li, Shiqiu Jiang, et al.
Brain Research Bulletin (2025) Vol. 222, pp. 111245-111245
Open Access

Investigating the Impact of NMDA Receptor Organization and Biological Sex in the APPswe/PS1dE9 Mouse Model of Alzheimer’s Disease
Senka Hadžibegović, Bruno Bontempi, Olivier Nicole
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1737-1737
Open Access

SNAP-25: A biomarker of synaptic loss in neurodegeneration
Chaoqun Zhang, Shanshan Xie, Michał Małek
Clinica Chimica Acta (2025), pp. 120236-120236
Closed Access

Oligomer sensitive in-situ detection and characterization of gold colloid aggregate formations observed within the hippocampus of the Alzheimer’s disease rat
Kazushige Yokoyama, Joel Mukkatt, Nicole Mathewson, et al.
Neuroscience Letters (2025), pp. 138218-138218
Closed Access

The Potential Role of Neurogranin in Alzheimer’s Disease
Xin Zhou, Xiaojun Jing, Hua Zhang
Journal of Integrative Neuroscience (2025) Vol. 24, Iss. 3
Open Access

Manganese Overexposure Alters Neurogranin Expression and Causes Behavioral Deficits in Larval Zebrafish
Anabel Alba‐González, Elena I. Dragomir, Golsana Haghdousti, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 4933-4933
Open Access | Times Cited: 4

Blood-Based Biomarkers in Alzheimer’s Disease: Advancing Non-Invasive Diagnostics and Prognostics
Mrinmay Dhauria, Ritwick Mondal, Shramana Deb, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 10911-10911
Open Access | Times Cited: 4

Biomarkers in Alzheimer’s Disease: Are Olfactory Neuronal Precursors Useful for Antemortem Biomarker Research?
Valeria Santillán-Morales, N. Rodríguez-Espinosa, Jesús Muñoz‐Estrada, et al.
Brain Sciences (2024) Vol. 14, Iss. 1, pp. 46-46
Open Access | Times Cited: 3

RETRACTED: Quercetin modulates expression of serum exosomal long noncoding RNA NEAT1 to regulate the miR-129-5p/BDNF axis and attenuate cognitive impairment in diabetic mice
Hui Wang, J. Narayanan, Tamilanban Thamaraikani, et al.
Life Sciences (2024) Vol. 340, pp. 122449-122449
Closed Access | Times Cited: 3

Correlation of Presynaptic and Postsynaptic Proteins with Pathology in Alzheimer’s Disease
Geidy E. Serrano, Jessica E. Walker, Courtney M. Nelson, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3130-3130
Open Access | Times Cited: 3

Raspberry Ketone Prevents LPS‐Induced Depression‐Like Behaviors in Mice by Inhibiting TLR‐4/NF‐κB Signaling Pathway via the Gut‐Brain Axis
Yike Liu, Chenlin Dai, Chendi Wang, et al.
Molecular Nutrition & Food Research (2024) Vol. 68, Iss. 11
Closed Access | Times Cited: 3

Role of Astrocytes in Alzheimer’s Disease Pathogenesis and the Impact of Exercise-induced Remodeling
Jie Shao, Qianting Deng, Shu Feng, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 732, pp. 150418-150418
Closed Access | Times Cited: 3

Evaluation of cerebrospinal fluid levels of synaptic vesicle protein, VAMP-2, across the sporadic Alzheimer’s disease continuum
Julie Goossens, Alba Cervantes‐González, Nele Dewit, et al.
Alzheimer s Research & Therapy (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 8

SNAP25 is a potential target for early stage Alzheimer’s disease and Parkinson’s disease
Qian Wang, Sijue Tao, Xing Lei, et al.
European journal of medical research (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 7

Page 1 - Next Page

Scroll to top